{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:50:14Z","timestamp":1793404214081,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10840-018-0433-0","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T11:33:56Z","timestamp":1533900836000},"page":"403-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system"],"prefix":"10.1007","volume":"52","author":[{"given":"Patrick","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-6277","authenticated-orcid":false,"given":"Fred","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"key":"433_CR1","doi-asserted-by":"crossref","unstructured":"Teare D Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20(1):1\u20138.","DOI":"10.1136\/hrt.20.1.1"},{"issue":"5","key":"433_CR2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(58)90021-4","volume":"25","author":"BA Bercu","year":"1958","unstructured":"Bercu BA, Diettert GA, Danforth WH, Pund EE Jr, Ahlvin RC, Belliveau RR. Pseudoaortic stenosis produced by ventricular hypertrophy. Am J Med. 1958;25(5):814.","journal-title":"Am J Med."},{"issue":"24","key":"433_CR3","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1161\/CIR.0b013e318223e2bd","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation. 2011;124(24):e783\u2013831.","journal-title":"Circulation"},{"issue":"5","key":"433_CR4","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1161\/01.CIR.80.5.1259","volume":"80","author":"L Fananapazir","year":"1989","unstructured":"Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO 3rd, Bonow RO, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation. 1989;80(5):1259\u201368.","journal-title":"Circulation"},{"issue":"5","key":"433_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","volume":"45","author":"AS Adabag","year":"2005","unstructured":"Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;45(5):697\u2013704.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"433_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0300-8932(10)70210-4","volume":"63","author":"R Barriales-Villa","year":"2010","unstructured":"Barriales-Villa R, Centuri\u00f3n-Inda R, Fern\u00e1ndez-Fern\u00e1ndez X, Ortiz MF, P\u00e9rez-Alvarez L, Rodr\u00edguez Garc\u00eda I, et al. Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol. 2010;63(8):985\u20138.","journal-title":"Rev Esp Cardiol"},{"issue":"2","key":"433_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1536\/jhj.45.347","volume":"45","author":"O Doven","year":"2004","unstructured":"Doven O, Cicek D, Pekdemir H, Camsari A, Parmaksiz T, Cin GV, et al. Abnormal His-Purkinje system conduction leading to complete atrioventricular block in patients with hypertrophic cardiomyopathy: a report of 3 cases. Jpn Heart J. 2004;45(2):347\u201352.","journal-title":"Jpn Heart J"},{"issue":"3","key":"433_CR8","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.ijcard.2006.12.050","volume":"125","author":"A Bahl","year":"2008","unstructured":"Bahl A, Saikia UN, Talwar KK. Familial conduction system disease associated with hypertrophic cardiomyopathy. Int J Cardiol. 2008;125(3):e44\u20137.","journal-title":"Int J Cardiol"},{"issue":"1","key":"433_CR9","doi-asserted-by":"publisher","first-page":"e000101","DOI":"10.1136\/openhrt-2014-000101","volume":"1","author":"S Grall","year":"2014","unstructured":"Grall S, Biere L, Clerfond G, Mateus V, Prunier F, Furber A. ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy. Open Heart. 2014;1(1):e000101.","journal-title":"Open Heart."},{"issue":"21","key":"433_CR10","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114(21):2232\u20139.","journal-title":"Circulation"},{"key":"433_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00000658-196108000-00003","volume":"154","author":"AG Morrow","year":"1961","unstructured":"Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaorticventriculomyotomy. Ann Surg. 1961;154:181\u20139.","journal-title":"Ann Surg"},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.CIR.24.4.739","volume":"24","author":"JW Kirklin","year":"1961","unstructured":"Kirklin JW, Ellis FH Jr. Surgical relief of diffuse subvalvular aortic stenosis. Circulation. 1961;24:739\u201342.","journal-title":"Circulation"},{"key":"433_CR13","first-page":"144","volume":"108","author":"R Brock","year":"1959","unstructured":"Brock R. Aortic subvalvar stenosis: surgical treatment. Guys Hosp Rep. 1959;108:144\u201358.","journal-title":"Guys Hosp Rep"},{"issue":"3","key":"433_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ejcts\/ezx398","volume":"53","author":"A Nguyen","year":"2018","unstructured":"Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, et al. Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy? Eur J Cardiothorac Surg. 2018;53(3):582\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"433_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.21037\/acs.2017.07.03","volume":"6","author":"KD Kotkar","year":"2017","unstructured":"Kotkar KD, Said SM, Dearani JA, Schaff HV. Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. Ann Cardiothorac Surg. 2017;6(4):329\u201336.","journal-title":"Ann Cardiothorac Surg"},{"issue":"8969","key":"433_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","volume":"346","author":"U Sigwart","year":"1995","unstructured":"Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346(8969):211\u20134.","journal-title":"Lancet"},{"issue":"9","key":"433_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/eurheartj\/ehr013","volume":"32","author":"MA Fifer","year":"2011","unstructured":"Fifer MA, Sigwart U. Controversies in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: alcohol septal ablation. Eur Heart J. 2011;32(9):1059\u201364.","journal-title":"Eur Heart J"},{"issue":"10","key":"433_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.amjcard.2010.07.017","volume":"106","author":"J Yuan","year":"2010","unstructured":"Yuan J, Qiao S, Zhang Y, You S, Duan F, Hu F, et al. Follow-up by cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy who underwent percutaneous ventricular septal ablation. Am J Cardiol. 2010;106(10):1487\u201391.","journal-title":"Am J Cardiol"},{"issue":"3","key":"433_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jacc.2006.08.055","volume":"49","author":"US Valeti","year":"2007","unstructured":"Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49(3):350\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"433_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ehf2.12178","volume":"4","author":"Y Hamatani","year":"2017","unstructured":"Hamatani Y, Amaki M, Kanzaki H, Yamashita K, Nakashima Y, Shibata A, et al. Contrast-enhanced computed tomography with myocardial three-dimensional printing can guide treatment in symptomatic hypertrophic obstructive cardiomyopathy. ESC Heart Fail. 2017;4(4):665\u20139.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"433_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cjca.2014.04.008","volume":"30","author":"W Chan","year":"2014","unstructured":"Chan W, Williams L, Kotowycz MA, Woo A, Rakowski H, Schwartz L, et al. Angiographic and echocardiographic correlates of suitable septal perforators for alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Can J Cardiol. 2014;30(8):912\u20139.","journal-title":"Can J Cardiol"},{"issue":"3","key":"433_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/ejcts\/ezs332","volume":"43","author":"S Wang","year":"2013","unstructured":"Wang S, Luo M, Sun H, Song Y, Yin C, Wang L, et al. A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China. Eur J Cardiothorac Surg. 2013;43(3):534\u201340.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"433_CR23","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2004.09.036","volume":"44","author":"DR Talreja","year":"2004","unstructured":"Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol. 2004;44(12):2329\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"433_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.amjcard.2003.09.034","volume":"93","author":"JX Qin","year":"2004","unstructured":"Qin JX, Shiota T, Lever HM, Asher CR, Popovi\u0107 ZB, Greenberg NL, et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol. 2004;93(2):171\u20135.","journal-title":"Am J Cardiol"},{"issue":"2","key":"433_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jtcvs.2009.10.045","volume":"140","author":"DH Kwon","year":"2010","unstructured":"Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. J Thorac Cardiovasc Surg. 2010;140(2):317\u201324.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"51","key":"433_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009371","volume":"96","author":"Y Lai","year":"2017","unstructured":"Lai Y, Guo H, Li J, Dai J, Ren C, Wang Y. Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy. Medicine (Baltimore). 2017;96(51):e9371.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"433_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jcin.2015.11.036","volume":"9","author":"M Liebregts","year":"2016","unstructured":"Liebregts M, Steggerda RC, Vriesendorp PA, van Velzen H, Schinkel AF, Willems R, et al. Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly. JACC Cardiovasc Interv. 2016;9(5):463\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"433_CR28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0002-9149(02)02693-0","volume":"90","author":"LH Runquist","year":"2002","unstructured":"Runquist LH, Nielsen CD, Killip D, Gazes P, Spencer WH 3rd. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2002;90(9):1020\u20132.","journal-title":"Am J Cardiol"},{"issue":"2","key":"433_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","volume":"119","author":"L Faber","year":"2007","unstructured":"Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances. Int J Cardiol. 2007;119(2):163\u20137.","journal-title":"Int J Cardiol"},{"issue":"5","key":"433_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.amjcard.2008.04.043","volume":"102","author":"E Coakley","year":"2008","unstructured":"Coakley E, Steinberg DH, Tibrewala A, Asch F, Pichard AD, Kent KM, et al. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern. Am J Cardiol. 2008;102(5):621\u20134.","journal-title":"Am J Cardiol"},{"issue":"1","key":"433_CR31","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1532\/HSF98.20091133","volume":"13","author":"OM Gomes","year":"2010","unstructured":"Gomes OM, Coelho AA, Osterne EC, Abrantes RD. Coronary morphology and conduction system disturbance induced by therapeutic embolization of the coronary septal artery. Heart Surg Forum. 2010;13(1):E45\u20138.","journal-title":"Heart Surg Forum"},{"issue":"3","key":"433_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/eurheartj\/ehm632","volume":"29","author":"E Durand","year":"2008","unstructured":"Durand E, Mousseaux E, Coste P, Pilli\u00e8re R, Dubourg O, Trinquart L, et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J. 2008;29(3):348\u201355.","journal-title":"Eur Heart J"},{"issue":"6","key":"433_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ccd.26668","volume":"88","author":"I Guerrero","year":"2016","unstructured":"Guerrero I, Dhoble A, Fasulo M, Denktas AE, Sami S, Choi S, et al. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 2016;88(6):971\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"433_CR34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","volume":"3","author":"M Liebregts","year":"2015","unstructured":"Liebregts M, Vriesendorp PA, Mahmoodi BK, Schinkel AF, Michels M, ten Berg JM. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. JACC Heart Fail. 2015;3(11):896\u2013905.","journal-title":"JACC Heart Fail"},{"issue":"8","key":"433_CR35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","volume":"55","author":"S Agarwal","year":"2010","unstructured":"Agarwal S, Tuzcu EM, Desai MY, Smedira N, Lever HM, Lytle BW, et al. Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;55(8):823\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"433_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","volume":"1","author":"LK Kim","year":"2016","unstructured":"Kim LK, Swaminathan RV, Looser P, Minutello RM, Wong SC, Bergman G, et al. Hospital volume outcomes after septal Myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US Nationwide inpatient database, 2003-2011. JAMA Cardiol. 2016;1(3):324\u201332.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"433_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cjca.2017.10.020","volume":"34","author":"J Veselka","year":"2018","unstructured":"Veselka J, Faber L, Jensen MK, Cooper R, Januska J, Krejci J, et al. Effect of institutional experience on outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Can J Cardiol. 2018;34(1):16\u201322.","journal-title":"Can J Cardiol."},{"issue":"11","key":"433_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cjca.2013.04.027","volume":"29","author":"J Veselka","year":"2013","unstructured":"Veselka J, Lawrenz T, Stellbrink C, Zemanek D, Branny M, Januska J, et al. Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy. Can J Cardiol. 2013;29(11):1415\u201321.","journal-title":"Can J Cardiol."},{"issue":"1","key":"433_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/joic.12178","volume":"28","author":"JL Schuller","year":"2015","unstructured":"Schuller JL, Zipse MM, Krantz MJ, Blaker B, Salcedo E, Groves BM, et al. Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy. J Interv Cardiol. 2015;28(1):90\u20137.","journal-title":"J Interv Cardiol"},{"key":"433_CR40","doi-asserted-by":"publisher","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SC, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2017. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.035\n                    \n                  .","DOI":"10.1016\/j.hrthm.2017.10.035"},{"issue":"21","key":"433_CR41","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","volume":"28","author":"CJ McLeod","year":"2007","unstructured":"McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, et al. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J. 2007;28(21):2583\u20138.","journal-title":"Eur Heart J"},{"issue":"3","key":"433_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/pace.12784","volume":"39","author":"VF Dijk Van","year":"2016","unstructured":"Van Dijk VF, Liebregts M, Luermans JG, Balt JC. Inappropriate shock due to T-wave oversensing by a subcutaneous ICD after alcohol septal ablation for hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2016;39(3):307\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"9","key":"433_CR43","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.hrthm.2016.04.018","volume":"13","author":"K Crossen","year":"2016","unstructured":"Crossen K, Jones M, Erikson C. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy. Heart Rhythm. 2016;13(9):1885\u201390.","journal-title":"Heart Rhythm"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-018-0433-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-018-0433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:10:44Z","timestamp":1565377844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-018-0433-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s10840-018-0433-0","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"3 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}